Wednesday, April 26, 2017

British Journal of Cancer - Table of Contents alert Volume 116 Issue 9

If you are unable to see the message below, click here to view.
British Journal of Cancer


Volume 116, Issue 9 (1119-1246)
Published online 25 April 2017

In this issue
Clinical Studies
Translational Therapeutics
Molecular Diagnostics

Also new today
Advance online publication
Digital Edition
Sign up for e-alerts Follow BJC on Twitter Follow us on Twitter

Sign up for e-alerts
Recommend to your library
Web feed



Personalising and targeting antiangiogenic resistance: a complex and multifactorial approach

Maria J Bueno, Silvana Mouron and Miguel Quintela-Fandino

Br J Cancer 2017 116: 1119-1125; advance online publication, March 16, 2017; 10.1038/bjc.2017.69

Abstract | Full Text

Clinical Studies


First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers

Eric Angevin, Nicolas Isambert, Véronique Trillet-Lenoir, Benoit You, Jérôme Alexandre, Gérard Zalcman, Philippe Vielh, Françoise Farace, Fanny Valleix, Thomas Podoll, Yu Kuramochi, Itaru Miyashita, Osamu Hosono, Nam H Dang, Kei Ohnuma, Taketo Yamada, Yutaro Kaneko and Chikao Morimoto

Br J Cancer 2017 116: 1126-1134; advance online publication, March 14, 2017; 10.1038/bjc.2017.62

Abstract | Full Text

Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and the Tenon score. Results of the NOTEGS study

Roman Rouzier, Catherine Uzan, Alexandra Rousseau, Eugénie Guillot, Sonia Zilberman, Charles Meyer, Pablo Estevez, Pierre-Francois Dupre, David Kere, Virginie Doridot, Gauthier D'halluin, Xavier Fritel, Nicolas Pouget, Clémentine Jankowski, Chafika Mazouni, Tabassome Simon and Charles Coutant

Br J Cancer 2017 116: 1135-1140; advance online publication, March 21, 2017; 10.1038/bjc.2017.47

Abstract | Full Text

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

Adi Nosrati, Katy K Tsai, Simone M Goldinger, Paul Tumeh, Barbara Grimes, Kimberly Loo, Alain P Algazi, Thi Dan Linh Nguyen-Kim, Mitchell Levesque, Reinhard Dummer, Omid Hamid and Adil Daud

Br J Cancer 2017 116: 1141-1147; advance online publication, March 21, 2017; 10.1038/bjc.2017.70

Abstract | Full Text

Does emergency presentation of cancer represent poor performance in primary care? Insights from a novel analysis of linked primary and secondary care data

Peter Murchie, Sarah M Smith, Michael S Yule, Rosalind Adam, Melanie E Turner, Amanda J Lee and Shona Fielding

Br J Cancer 2017 116: 1148-1158; advance online publication, March 23, 2017; 10.1038/bjc.2017.71

Abstract | Full Text

The PICTURE study: diagnostic accuracy of multiparametric MRI in men requiring a repeat prostate biopsy

Lucy A M Simmons, Abi Kanthabalan, Manit Arya, Tim Briggs, Dean Barratt, Susan C Charman, Alex Freeman, James Gelister, David Hawkes, Yipeng Hu, Charles Jameson, Neil McCartan, Caroline M Moore, Shonit Punwani, Navin Ramachandran, Jan van der Meulen, Mark Emberton and Hashim U Ahmed

Br J Cancer 2017 116: 1159-1165; advance online publication, March 28, 2017; 10.1038/bjc.2017.57

Abstract | Full Text

Translational Therapeutics


Characterisation of CCT271850, a selective, oral and potent MPS1 inhibitor, used to directly measure in vivo MPS1 inhibition vs therapeutic efficacy

Amir Faisal, Grace W Y Mak, Mark D Gurden, Cristina P R Xavier, Simon J Anderhub, Paolo Innocenti, Isaac M Westwood, Sébastien Naud, Angela Hayes, Gary Box, Melanie R Valenti, Alexis K De Haven Brandon, Lisa O'Fee, Jessica Schmitt, Hannah L Woodward, Rosemary Burke, Rob L M vanMontfort, Julian Blagg, Florence I Raynaud, Suzanne A Eccles, Swen Hoelder and Spiros Linardopoulos

Br J Cancer 2017 116: 1166-1176; advance online publication, March 23, 2017; 10.1038/bjc.2017.75

Abstract | Full Text

High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients

Tuya Bai, Takehiko Yokobori, Bolag Altan, Munenori Ide, Erito Mochiki, Mitsuhiro Yanai, Akiharu Kimura, Norimichi Kogure, Toru Yanoma, Masaki Suzuki, Pinjie Bao, Kyoichi Kaira, Takayuki Asao, Ayaka Katayama, Tadashi Handa, Navchaa Gombodorj, Masahiko Nishiyama, Tetsunari Oyama, Kyoichi Ogata and Hiroyuki Kuwano

Br J Cancer 2017 116: 1177-1185; advance online publication, March 23, 2017; 10.1038/bjc.2017.76

Abstract | Full Text

Multinucleated polyploidy drives resistance to Docetaxel chemotherapy in prostate cancer

Karuna Mittal, Shashi Donthamsetty, Ramneet Kaur, Chunhua Yang, Meenakshi V Gupta, Michelle D Reid, Da Hoon Choi, Padmashree C G Rida and Ritu Aneja

Br J Cancer 2017 116: 1186-1194; advance online publication, March 23, 2017; 10.1038/bjc.2017.78

Abstract | Full Text

SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour

Olli-Pekka Pulkka, Bengt Nilsson, Maarit Sarlomo-Rikala, Peter Reichardt, Mikael Eriksson, Kirsten Sundby Hall, Eva Wardelmann, Aki Vehtari, Heikki Joensuu and Harri Sihto

Br J Cancer 2017 116: 1195-1202; advance online publication, March 23, 2017; 10.1038/bjc.2017.82

Abstract | Full Text

LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma

Sei Naito, Peter Makhov, Igor Astsaturov, Konstantin Golovine, Alexei Tulin, Alexander Kutikov, Robert G Uzzo and Vladimir M Kolenko

Br J Cancer 2017 116: 1203-1207; advance online publication, March 28, 2017; 10.1038/bjc.2017.77

Abstract | Full Text

Molecular Diagnostics


MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue

Hormas Ghadially, Lee Brown, Chris Lloyd, Leeanne Lewis, Arthur Lewis, Janette Dillon, Richard Sainson, Jelena Jovanovic, Natalie J Tigue, David Bannister, Lisa Bamber, Viia Valge-Archer and Robert W Wilkinson

Br J Cancer 2017 116: 1208-1217; advance online publication, March 23, 2017; 10.1038/bjc.2017.79

Abstract | Full Text

Human papillomavirus 16 is an aetiological factor of scrotal cancer

Núria Guimerà, Laia Alemany, Gordana Halec, Michael Pawlita, Gerard Vincent Wain, José Santos Salas Vailén, Jerome E Azike, David Jenkins, Silvia de Sanjosé, Wim Quint and F Xavier Bosch

Br J Cancer 2017 116: 1218-1222; advance online publication, April 4, 2017; 10.1038/bjc.2017.74

Abstract | Full Text



Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium

Suzanne C Dixon, Christina M Nagle, Nicolas Wentzensen, Britton Trabert, Alicia Beeghly-Fadiel, Joellen M Schildkraut, Kirsten B Moysich, Anna deFazio, Australian Ovarian Cancer Study Group, Harvey A Risch, Mary Anne Rossing, Jennifer A Doherty, Kristine G Wicklund, Marc T Goodman, Francesmary Modugno, Roberta B Ness, Robert P Edwards, Allan Jensen, Susanne K Kjær, Estrid Høgdall, Andrew Berchuck, Daniel W Cramer, Kathryn L Terry, Elizabeth M Poole, Elisa V Bandera, Lisa E Paddock, Hoda Anton-Culver, Argyrios Ziogas, Usha Menon, Simon A Gayther, Susan J Ramus, Aleksandra Gentry-Maharaj, Celeste Leigh Pearce, Anna H Wu, Malcolm C Pike and Penelope M Webb on behalf of the Ovarian Cancer Association Consortium

Br J Cancer 2017 116: 1223-1228; advance online publication, March 28, 2017; 10.1038/bjc.2017.68

Abstract | Full Text

Dependence of cancer risk from environmental exposures on underlying genetic susceptibility: an illustration with polycyclic aromatic hydrocarbons and breast cancer

Jing Shen, Yuyan Liao, John L Hopper, Mandy Goldberg, Regina M Santella and Mary Beth Terry

Br J Cancer 2017 116: 1229-1233; advance online publication, March 28, 2017; 10.1038/bjc.2017.81

Abstract | Full Text

Acid-suppressing therapies and subsite-specific risk of stomach cancer

E Christina M Wennerström, Jacob Simonsen, M Constanza Camargo and Charles S Rabkin

Br J Cancer 2017 116: 1234-1238; advance online publication, March 28, 2017; 10.1038/bjc.2017.84

Abstract | Full Text

Sleep and survival among women with breast cancer: 30 years of follow-up within the Nurses’ Health Study

Claudia Trudel-Fitzgerald, Eric S Zhou, Elizabeth M Poole, Xuehong Zhang, Karin B Michels, A Heather Eliassen, Wendy Y Chen, Michelle D Holmes, Shelley S Tworoger and Eva S Schernhammer

Br J Cancer 2017 116: 1239-1246; advance online publication, March 30, 2017; 10.1038/bjc.2017.85

Abstract | Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: